Quantcast

Latest Artificial heart Stories

2011-02-26 00:00:03

21-Year-Old Mom Returns Home to 9-Month-Old Son and Husband to Wait for Matching Donor Heart Tucson, AZ (Vocus/PRWEB) February 24, 2011 On Jan. 20, Marcela Padilla, 21, became the first woman and the fifth person in the U.S. to leave the hospital using the Freedom® portable driver to power her SynCardia temporary Total Artificial Heart. The Tucson mom was discharged from University Medical Center (UMC) just in time to celebrate her 21st birthday at home with her husband and 9-month-old...

2011-01-24 06:00:00

ANN ARBOR, Mich., Jan. 24, 2011 /PRNewswire/ -- The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure. The National Heart, Lung and Blood Institute and HeartWare (Nasdaq: HTWR), a maker of left ventricular assist devices, are sponsoring the study of earlier access to these devices that support the circulation of...

2011-01-21 00:00:51

Two Turkish Hospitals and Two U.S. Centers to Complete Phase I in January Tucson, Ariz. (Vocus/PRWEB) January 20, 2011 On Jan. 20, SynCardia Systems, Inc. announced that four new hospitals, two in Turkey and two in the U.S., have begun certification to implant the SynCardia temporary Total Artificial Heart as a bridge to transplant. The four centers have, or will complete the first of four phases of certification during the month of January.     Kartal Kosuyolu Yuksek...

2010-11-15 12:16:12

Young father receives leading-edge intervention prior to undergoing heart transplant James "Jimmy" Armstrong hadn't missed a "Mac" in 28 years. At 44, he's one of the youngest "goats" in the Chicago Yacht Club. Sailors receive the designation of "goat" once they've completed 20 or more "Macs", the 333-mile boat race from Chicago to Mackinac, Michigan. Armstrong has sailed the race every year since he was 16. But, he wasn't among the sailors this past July. Instead, he was in intensive care...

2010-11-14 08:00:00

FRAMINGHAM, Mass. and SYDNEY, Nov. 14, 2010 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR) (ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its pivotal bridge to heart transplantation (BTT) study, ADVANCE, showed that 92% of the investigational device patients met the per protocol primary endpoint of the trial, which was...

2010-10-21 15:24:00

Participants review progress of 39-month study HOUSTON, Oct. 21 /PRNewswire-USNewswire/ -- Investigators from Texas Children's Hospital and 16 other top pediatric heart centers in North America came together in Houston to analyze results from their 39-month national clinical trial of the Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD), a German-manufactured pediatric mechanical heart. To learn more about the study, see: http://bit.ly/bfrA1J (Photo:...

2010-10-12 16:41:07

In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure. The new device is longer lasting than older generation LVADs and may eliminate the need for a second LVAD "“ a major drawback with the old technology. The patient, 61-year-old Marva Lorde of Mississauga, suffered a heart attack in 2007 and underwent several treatments for heart failure "“ including a 10-day intensive care unit...

2010-09-03 17:38:00

FRAMINGHAM, Mass. and SYDNEY Sept. 3 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE"...

2010-06-15 01:02:29

Heart failure is a very common condition: around 200,000 people in Sweden have been diagnosed with the disease. Some patients with life-threatening heart failure can be helped by mechanical heart pumps, reveals a thesis from the University of Gothenburg, Sweden. In the thesis, a total of 99 patients with life-threatening heart failure were treated with a heart pump for short- or long-term circulatory support. "Two-thirds of these patients survived," says Hans Lid©n, a researcher at the...

2010-06-14 15:10:00

FRAMINGHAM, Mass. and SYDNEY, June 14 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted HeartWare conditional approval to begin enrollment in an Investigational Device Exemption (IDE) destination therapy clinical study for the...


Latest Artificial heart Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related